XML 40 R29.htm IDEA: XBRL DOCUMENT v3.21.2
CHANGE IN CONTROL AND REVERSE RECAPITALIZATION TRANSACTIONS (Details) - USD ($)
Apr. 30, 2021
Jan. 31, 2021
Oct. 31, 2020
Jul. 31, 2020
Apr. 30, 2020
Apr. 13, 2020
Feb. 10, 2020
Preferred stock $ 202     $ 202      
Common stock 12,627     9,669      
Additional paid-in capital 3,879,095     1,456,644      
Adjustment to stockholders' equity (deficiency) 1,426,331 $ 819,826 $ 147,250 (150,341) $ (110,540)  
Series B Preferred Stock              
Preferred stock $ 72     $ 72      
Bio-Matrix Scientific Group, Inc              
Cash           $ 572  
Investment securities           8,797  
Total current assets           9,369  
Preferred stock           202  
Common stock           781  
Additional paid-in capital           8,314  
Adjustment to stockholders' equity (deficiency)           9,369  
Bio-Matrix Scientific Group, Inc | Series B Preferred Stock              
Preferred stock           $ 72